Condition
Pain, Nerve
Total Trials
6
Recruiting
3
Active
3
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
17%
1 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
6Total
Not Applicable (3)
P 2 (2)
P 4 (1)
Trial Status
Recruiting3
Unknown1
Completed1
Withdrawn1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT07550348Not ApplicableRecruiting
Bupivacaine-Lidocaine vs Bupivacaine for Ultrasound-Guided Popliteal Sciatic Nerve Block
NCT06185816Phase 2RecruitingPrimary
Non-Invasive Pulsed Radiofrequency for the Treatment of Neuropathic Pain
NCT05009394Not ApplicableRecruiting
Surgical Treatments for Postamputation Pain
NCT06460194Phase 2Withdrawn
Treatment of Frostbite Sequelae With Botulinum Toxin A
NCT04653792Phase 4CompletedPrimary
Role Of Pregabalin To Decrease Postoperative Pain In Microdiscectomy
NCT03494842Not ApplicableUnknown
TENS for Suction Evacuation for Termination of 1st Trimester Pregnancies
Showing all 6 trials